“…RIA and ELISA have been largely replaced by fully automated CLIA assays. In addition, there are burgeoning technologies for CEA detection in recent decades, such as a signal-on/split-type photoelectrochemical sensing approach, an enhanced pressure-based immunoassay and a novel homogeneous visual fluorescence sensing system [ [7] , [8] , [9] , [10] ]. The reason to compare assays is to assure that patients with a disease will be equally classified by all clinically validated assays and that monitoring may be recommended performed using the same assays, or independently from the assays if results are interchangeable.…”